Acute COPD exacerbations

Clinics in Chest Medicine

Volumn 35, Issue 1, 2014, Pages 157-163

  Wedzicha, Jadwiga A ^a   Singh, Richa ^a   Mackay, Alex J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Bacterial infections; COPD; Exacerbations; Respiratory viral infections

Indexed keywords

BACTERIAL INFECTIONS; COPD; EXACERBATIONS; RESPIRATORY VIRAL INFECTIONS;

ACUTE DISEASE; ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; BRONCHODILATOR AGENTS; HOSPITALIZATION; HUMANS; OXYGEN INHALATION THERAPY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84893517970     PISSN: 02725231     EISSN: 15578216     Source Type: Journal    
DOI: 10.1016/j.ccm.2013.11.001     Document Type: Review

References (30)

1. Wedzicha J.A., Seemungal T.A. COPD exacerbations: defining their cause and prevention. Lancet 2007, 370:786-796.
2. Donaldson G.C., Seemungal T.A., Bhowmik A., et al. The relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002, 57:847-852.
3. National Institute for Health and Clinical Excellence (NICE). Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. Update 2010. Available at: Accessed December 18, 2013. http://guidance.nice.org.uk/CG101/Guidance/pdf/English.
4. Donaldson G.C., Hurst J.R., Smith C.J., et al. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest 2010, 137:1091-1097.
5. McAllister D.A., Maclay J.D., Mills N.L. Diagnosis of myocardial infarction following hospitalisation for exacerbation of COPD. Eur Respir J 2012, 39:1097-1103.
6. Suissa S., Dell'Aniello S., Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax 2012, 67(11):957-963.
7. Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global strategy for the diagnosis, management and prevention of COPD. GOLD. Am J Respir Crit Care Med 2013, Available at:, Accessed December 18, 2013. http://www.goldcopd.org.
8. Wilkinson T.M., Donaldson G.C., Hurst J.R., et al. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004, 169:1298-1303.
9. Mackay A.J., Donaldson G.C., Patel A.R., et al. Detection and severity grading of COPD exacerbations using the exacerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT). Eur Respir J 2013, 10.1183/09031936.00110913.
10. Mackay A.J., Donaldson G.C., Patel A.R., et al. Usefulness of the Chronic Obstructive Pulmonary Disease assessment test to evaluate severity of COPD exacerbations. Am J Respir Crit Care Med 2012, 185:1218-1224.
11. Seemungal T.A., Harper-Owen R., Bhowmik A., et al. Respiratory viruses, symptoms and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 164:1618-1623.
12. Peacock J.L., Anderson H.R., Bremner S.A., et al. Outdoor air pollution and respiratory health in patients with COPD. Thorax 2011, 66:591-596.
13. Seemungal T.A., Donaldson G.C., Paul E.A., et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 157:1418-1422.
14. Hurst J.R., Vestbo J., Anzueto A., et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. NEngl J Med 2010, 63:1128-1138.
15. Wedzicha J.A., Brill S.E., Allinson J.P., et al. Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease. BMC Medicine 2013, 11:181.
16. Nichol K.L., Nordin J.D., Nelson D.B., et al. Effectiveness of influenza vaccine in the community-dwelling elderly. NEngl J Med 2007, 357:1373-1381.
17. Calverley P.M., Anderson J.A., Celli B., et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. NEngl J Med 2007, 356:775-789.
18. Tashkin D.P., Celli B., Senn S., et al. A4-year trial of tiotropium in chronic obstructive pulmonary disease. NEngl J Med 2008, 359:1543-1554.
19. Vogelmeier C., Hederer B., Glaab T., et al. Tiotorpium versus salmeterol for the prevention of COPD exacerbations. NEngl J Med 2011, 364(12):1093-1103.
20. Wedzicha J.A., Decramer M., Fucker J.H., et al. Analysis of COPD exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomized, double-blind, parallel-group study. Lancet Respir Med 2013, 1:199-209.
21. Calverley P.M., Rabe K.F., Goehring U.M., et al. M2-124 and M2-125 study groups. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet 2009, 374(9691):685-694. [Erratum appears in Lancet 2010;376(9747):1146].
22. Wedzicha J.A., Rabe K.F., Martinez F.J., et al. Efficacy of roflumilast in the COPD frequent exacerbator phenotype. Chest 2013, 143:1302-1311.
23. Seemungal T.A., Wilkinson T., Hurst J.R., et al. Effect of erythromycin on exacerbations in COPD. Am J Respir Crit Care Med 2008, 178:1139-1147.
24. Albert R.K., Connett J., Bailey W.C., et al. Azithromycin for prevention of exacerbations of COPD. NEngl J Med 2011, 365:689-698.
25. Sethi S., Jones P.W., Theron M.S., PULSE Study group, et al. Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Respir Res 2010, 11:10.
26. McEvoy R.D., Pierce R.J., Hillman D., et al. Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trial. Thorax 2009, 64:561-566.
27. Anthonisen N.R., Manfreda J., Warren C.P., et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987, 106:196-204.
28. Leuppi J.D., Schuetz P., Bingisser R. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease the REDUCE randomized clinical trial. JAMA 2013, 309(21):2223-2231.
29. Roede B.M., Bresser P., Bindels P.J., et al. Antibiotic treatment is associated with a reduced risk of a subsequent exacerbation in obstructive lung disease: a historical population-based cohort. Thorax 2008, 63(11):968-973.
30. Hurst J.R., Donaldson G.C., Quint J.K., et al. Temporal clustering of exacerbations in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009, 179:369-374.